Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin nasal spray for alcohol dependence
ACTRN12617001626358Phase 3Recruiting
- Sponsor
- The University of Sydney
- Start
- Feb 2019
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in alcohol dependence comparing Oxytocin nasal spray with Placebo nasal spray (2 arms). Primary endpoint: Reduction in heavy drinking days. Started Feb 2019; status: recruiting.
02
Drugs
oxytocin
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on ACTRN12617001626358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001626358.